comparemela.com

Latest Breaking News On - Teva europe - Page 1 : comparemela.com

Outsourcing active medicine ingredients leaves EU patients at risk

Teva warns APIs could disappear from European factories in five to 10 years if outsourcing essential medicine manufacture continues.

Teva europePhilippe drechsleAddressing europeMedicine exodusWestern europePharmaceutical legislationPatient information

Report: Energy crisis accelerating exodus of companies from Europe

Europe’s drugmakers have warned they may stop making some cheap generic medicines due to surging energy costs.

United statesTeva europePhilippe drechsleErick tyssierEport energy crisis accelerating exodus of companies from europeUkraine crisisGeneric medicine

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis
dutchnews.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dutchnews.nl Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandThomas haleTeva europeKerstin hellwigDanilo lemboSaneea almasKatholisches klinikum bochumFiona cohenTeresa bakerJesse vanceDepartment of neurologySclerosis international volumeTeva pharmaceuticals europeRuhr university bochumTeva pharmaceuticals

New Safety Data on treatment with COPAXONE® (glatiramer acetate) of Breastfeeding Mothers who Live with Relapsing Multiple Sclerosis

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesTeva europeKerstin hellwigDanilo lemboKatholisches klinikum bochumFiona cohenDepartment of neurologyTeva pharmaceuticals europeTeva pharmaceutical industriesRuhr university bochumTeva pharmaceuticalsTeva pharmaceutical industries ltdJosef hospitalPrincipal study investigatorGerman multiple sclerosisPregnancy registry

Juan Carlos Conde, nuevo Director General de Teva para España y Portugal

Juan Carlos Conde, nuevo Director General de Teva para España y Portugal PMFarma utiliza cookies propias y de terceros para recopilar informacion con la finalidad de mejorar nuestros servicios y mostrarte publicidad relacionada con tus preferencias. Al continuar navegando por el sitio, aceptas el uso de las mismas. Tienes la posibilidad de configurar tu navegador pudiendo impedir que sean instaladas. Configurar | Aceptar Toggle navigation Juan Carlos Conde, nuevo Director General de Teva para España y Portugal Con más de 17 años de experiencia en la compañía farmacéutica, Juan Carlos Conde sustituirá en el cargo a Carlos Teixeira.

Czech republicSlovak republicJohn karl condeTeva europeKarl teixeiraA business development managersYour mission itNew director generalTeva hasPortugal to john karl condePost to karl teixeiraJohn karl conde will takeBusiness development managersPost as director generalசெக் குடியரசுஸ்லோவாக் குடியரசு

vimarsana © 2020. All Rights Reserved.